Skip to main content
Trending
Visa regulationsCentral bank balance sheetCamp david accordsTax strategyNuclear strategyHabeas corpusViking archaeologyRunning biomechanicsNfl analyticsResearch ethicsStudy environmentGolden visasNeural architecturesNegotiation strategyEuropean portsCocktail chemistryLabor organizingAttention mechanismDatabase securityEnergy economicsPassport regulationsSteam frameReactor physicsPayment processingSurvey methodologyTech regulationCorporate financeSalary cap mechanicsSudan conflictRecord relief

Health

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Explainer

FDA Approves First-in-Class Protein Degrader Vepdegestrant for Advanced Breast Cancer

5 sources · 42d ago

Allergy Care

FDA Removes Age Limits on Needle-Free Epinephrine Nasal Spray, Expanding Access for Young Children

6 sources · 42d ago

Explainer

Immunotherapy Combination Achieves 96% Disease-Free Survival in Childhood Leukemia Trial

5 sources · 42d ago

More in Health

ExplainerSleep Medicine

FDA Approves Zepbound as First Drug Treatment for Obstructive Sleep Apnea

Sleep Medicine Clinicians 36%Cardiometabolic Researchers 36%Patient Advocates 29%

4 sources · 42d ago

ExplainerALS Biomarkers

New Blood Test Predicts ALS Onset Years in Advance, Paving Way for Preventative Trials

Clinical Researchers 40%Patient Advocacy Groups 30%Medical Analysts 30%

4 sources · 18d ago

ExplainerCholesterol Guidelines

New Cholesterol Guidelines Make Over Half of U.S. Adults Eligible for Statin Therapy

Clinical Guideline Authors 40%Public Health Researchers 40%Independent Synthesis 20%

5 sources · 43d ago

Research BriefPancreatic Cancer

New KRAS Inhibitor Daraxonrasib Nearly Doubles Survival in Late-Stage Pancreatic Cancer Trial

Clinical Oncologists 40%Patient Advocates 30%Regulatory & Industry Analysts 30%

7 sources · 43d ago

Cancer ScreeningExplainer

FDA Clears At-Home HPV Self-Collection Kits, Expanding Cervical Cancer Screening Access

Public Health Officials 40%Clinical Providers 35%Patient Advocates 25%

6 sources · 43d ago

Advanced Prostate CancerTreatment Breakthrough

New Drug Combinations Significantly Extend Survival for Late-Stage Prostate Cancer

Clinical Oncologists 40%Precision Medicine Advocates 35%Patient Quality-of-Life Advocates 25%

6 sources · 43d ago

Research BriefLongevity Genetics

Landmark Study Reveals Male and Female Aging Driven by 'Entirely Distinct' Genetic Programs

Precision Longevity Advocates 40%Clinical Gerontologists 35%Systems Biologists 25%

7 sources · 43d ago

ExplainerPediatric Medicine

FDA Approves First Gene Therapy for Young Children With Sickle Cell Disease

Clinical Researchers 35%Patient Advocates 35%Medical Ethicists 30%

2 sources · 43d ago

ExplainerGenetic Medicine

FDA Approves First Gene Therapy to Treat Inherited Hearing Loss Caused by OTOF Mutations

Medical Researchers 35%Patient Advocacy Groups 35%Regulatory Experts 30%

4 sources · 44d ago

Menopause CarePolicy Reversal

FDA Removes Boxed Warnings for Breast Cancer and Dementia from Menopausal Hormone Therapy

Women's Health Advocates 45%Regulatory Leadership 35%Breast Cancer Organizations 20%

7 sources · 44d ago

ExplainerNeuromodulation

Implanted Vagus Nerve Stimulator Provides Durable, Two-Year Relief for Severe Depression

Clinical Researchers 40%Patient Advocates 35%Methodologists & Skeptics 25%

6 sources · 45d ago

Research BriefCellular Reprogramming

FDA Greenlights First Human Trial to Reverse Cellular Aging With Yamanaka Factors

Cellular Rejuvenation Proponents 40%Translational Biologists 30%Clinical Safety Regulators 30%

6 sources · 45d ago

Research BriefYouth Mental Health

National Survey Finds Significant Drop in Adolescent Depression and Suicidal Thoughts for First Time in Years

Public Health Officials 40%Clinical Psychiatrists 35%Local Government Advocates 25%

6 sources · 45d ago

ExplainerPsychiatric Medicine

FDA Clears First New-Mechanism Schizophrenia Drug in 30 Years

Psychiatric Researchers 44%Clinical Practitioners 33%Patient Advocates & Skeptics 22%

6 sources · 45d ago

Thyroid Eye DiseaseDrug Approval

Landmark Approval: First-in-Class Drug Lumvoa Cleared for Thyroid Eye Disease, Treating Both Active and Chronic Stages

Clinical Ophthalmologists 40%Patients & Advocates 35%Industry & Market Analysts 25%

7 sources · 49d ago

Supplement RegulationExplainer

U.S. Physicians' Group Demands Congress Overhaul DSHEA, Require Pre-Market Approval for All Dietary Supplements

Medical Consensus 45%Supplement Industry 45%Legislative Reformers 10%

6 sources · 51d ago

KRAS InhibitorsClinical Trial Results

Next-Generation KRAS Inhibitor Divarasib Shows Superiority Over Approved Drugs in Head-to-Head Lung Cancer Trial

Clinical Oncologists 40%Market Analysts 30%Drug Developers 30%

8 sources · 51d ago

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy